Items Tagged ‘immunotherapies’

UCLA Health Research and Innovation puts novel ideas into practice to benefit patients and providers

May 29, 2019

UCLA Health Research and Innovation puts novel ideas into practice to benefit patients and providers

By uclahealth uclahealth

UCLA Health continues to be a leader in pioneering health care innovations that benefit patients and practitioners across the globe. Past discoveries at UCLA include first-of-their-kind immunotherapies, advanced imaging scans and apps that optimize patient care. UCLA Health Research and Innovation is dedicated to fostering the development of novel health care concepts. “Our goal is […]

View full entry

Tags: Desert Horse-Grant, immunotherapies, Innovation Challenge, UCLA Biodesign, UCLA Biodesign Fellowship, UCLA Health Research and Innovation


18-Year Brain Tumor Survivor Thriving from 3rd Awake Brain Surgery & Immunotherapy Vaccine from Dr. Linda Liau at UCLA

November 30, 2016

18-Year Brain Tumor Survivor Thriving from 3rd Awake Brain Surgery & Immunotherapy Vaccine from Dr. Linda Liau at UCLA

By jwals jwals

Jeannine Walston shares her story, with detailed information about her experience at UCLA, Dr. Liau, brain surgery, immunotherapy vaccine, and how to support research.

View full entry

Tags: awake brain surgery, blood biomarkers, brain cancer vaccines, brain tumor, brain tumors, cancer, chemotherapy, clinical trials, DCVax-L vaccine, Dr. Linda Liau MD PhD, functional brain mapping, functional MRI


Blood-cancer research, patients focus of “Light The Night” walk

October 24, 2016

Blood-cancer research, patients focus of “Light The Night” walk

By Roxanne Moster Roxanne Moster

With invitations to so many worthy medical causes and events, it becomes a difficult decision to figure out how to devote your time and energy.  But a colleague who was diagnosed with a blood cancer gave me a laser focus on an upcoming event. Like my treasured co-worker, Jassmine Ahumada’s 7-year-old son, Rey, should be […]

View full entry

Tags: adult leukemia, American Society of Hematology, blood cancer, blood cells, bone marrow, cancer, cancer survivors, cancer treatment, chemotherapy, clinical trials, Dr. John Timmerman, engineered T cells